IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 6 holdings | $23.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tourmaline BIO Inc(TRML)COM89157D105$11.3M741,69148.8%
Korro BIO Inc(KRRO)COM500946108$6.4M368,08527.7%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$4.0M928,96417.3%
Hillevax IncCOM43157M102$540.3K372,6152.3%
Ventyx Biosciences Inc(VTYX)COM92332V107$474.1K412,2252.1%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$404.4K82,8711.8%